Q-omics provides the consensus-scored RNU6-239P profile across patient tissues and cancer cell-line models. RNU6-239P expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, RNU6-239P RNA expression shows 6,269 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUSC, and STAD as cancer lineages where RNU6-239P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-239P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-239P survival associations across molecular data types. RNU6-239P RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-239P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	LUSC (108)	view →

This table ranks reproducible RNU6-239P RNA expression–survival associations across cancer types. High RNU6-239P expression shows unfavorable associations in LUSC, ACC, LIHC, ESCA, STAD and UCS. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUSC as the clearest survival context for RNU6-239P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.206	0.777	<.001	108	view →
ACC	OS	Tertile	All	0.273	0.802	.017	45	view →
LIHC	OS	Tertile	All	0.213	0.777	.009	45	view →
ESCA	OS	Tertile	All	0.210	0.909	.008	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →

Pink = unfavorable, green = favorable. all 6 lineages →

RNU6-239P-LUSC (OS)

Kaplan–Meier survival curve for RNU6-239P RNA expression in LUSC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-239P in patient tissues and cancer cell lines. In patient samples, RNU6-239P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,269	STAD (6082)	view →
RNA	3,920	STAD (1468)	view →